Cargando…

PCDH1 promotes progression of pancreatic ductal adenocarcinoma via activation of NF-κB signalling by interacting with KPNB1

Uncontrolled growth, distant metastasis and chemoresistance are critical characteristics of pancreatic ductal adenocarcinoma (PDAC), and they result in high mortality; however, the mechanisms triggering these effects have not been fully investigated. In this study, we analysed a dataset in the Cance...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ye, Zhihua, Yang, Yingyu, Wei, Ying, Li, Lamei, Wang, Xinyi, Zhang, Junkai
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9304345/ https://www.ncbi.nlm.nih.gov/pubmed/35864095 http://dx.doi.org/10.1038/s41419-022-05087-y

Ejemplares similares

High methylation levels of PCDH10 predict poor prognosis in patients with pancreatic ductal adenocarcinoma
por: Curia, Maria Cristina, et al.
Publicado: (2019)

Decreased KPNB1 Expression is Induced by PLK1 Inhibition and Leads to Apoptosis in Lung Adenocarcinoma
por: Sekimoto, Noboru, et al.
Publicado: (2017)

OXCT1 Enhances Gemcitabine Resistance Through NF-κB Pathway in Pancreatic Ductal Adenocarcinoma
por: Ding, Jinsheng, et al.
Publicado: (2021)

CircKPNB1 mediates a positive feedback loop and promotes the malignant phenotypes of GSCs via TNF-α/NF-κB signaling
por: Jiang, Yang, et al.
Publicado: (2022)

Tumor-associated macrophages promote progression and the Warburg effect via CCL18/NF-kB/VCAM-1 pathway in pancreatic ductal adenocarcinoma
por: Ye, Huilin, et al.
Publicado: (2018)

PCDH1, a poor prognostic biomarker and potential target for pancreatic adenocarcinoma metastatic therapy
por: Du, Xingyi, et al.
Publicado: (2023)

GNG12 regulates PD‐L1 expression by activating NF‐κB signaling in pancreatic ductal adenocarcinoma
por: Li, Juan, et al.
Publicado: (2020)

KPNB1 mediates PER/CRY nuclear translocation and circadian clock function
por: Lee, Yool, et al.
Publicado: (2015)

NF1 loss of function as an alternative initiating event in pancreatic ductal adenocarcinoma
por: Ramakrishnan, Gopalakrishnan, et al.
Publicado: (2022)

The Expressions of NF−κB, COX−2, Sp1, and c−Jun in Pancreatic Ductal Adenocarcinoma and Their Associations with Patient Survival
por: Renaldi, Kaka, et al.
Publicado: (2023)

PSC-derived Galectin-1 inducing epithelial-mesenchymal transition of pancreatic ductal adenocarcinoma cells by activating the NF-κB pathway
por: Tang, Dong, et al.
Publicado: (2017)

Positive Crosstalk Between Hedgehog and NF-κB Pathways Is Dependent on KRAS Mutation in Pancreatic Ductal Adenocarcinoma
por: Wang, Yuqiong, et al.
Publicado: (2021)

Progress in Animal Models of Pancreatic Ductal Adenocarcinoma
por: Kong, Kaiwen, et al.
Publicado: (2020)

FEZF1-AS1/miR-107/ZNF312B axis facilitates progression and Warburg effect in pancreatic ductal adenocarcinoma
por: Ye, Huilin, et al.
Publicado: (2018)

Pancreatic Satellite Cells Derived Galectin-1 Increase the Progression and Less Survival of Pancreatic Ductal Adenocarcinoma
por: Tang, Dong, et al.
Publicado: (2014)

Correction: PSC-derived Galectin-1 inducing epithelial-mesenchymal transition of pancreatic ductal adenocarcinoma cells by activating the NF-κB pathway
por: Tang, Dong, et al.
Publicado: (2021)

Targeting KPNB1 overcomes TRAIL resistance by regulating DR5, Mcl-1 and FLIP in glioblastoma cells
por: Zhu, Zhi-Chuan, et al.
Publicado: (2019)

Locally Advanced Pancreatic Ductal Adenocarcinoma: Challenges and Progress
por: Barcellini, Amelia, et al.
Publicado: (2020)

KPNB1 inhibition disrupts proteostasis and triggers unfolded protein response-mediated apoptosis in glioblastoma cells
por: Zhu, Zhi-Chuan, et al.
Publicado: (2018)

Unconventional tonicity-regulated nuclear trafficking of NFAT5 mediated by KPNB1, XPOT and RUVBL2
por: Cheung, Chris Y., et al.
Publicado: (2022)

circCUL2 induces an inflammatory CAF phenotype in pancreatic ductal adenocarcinoma via the activation of the MyD88-dependent NF-κB signaling pathway
por: Zheng, Shangyou, et al.
Publicado: (2022)

Contribution of nuclear BCL10 expression to tumor progression and poor prognosis of advanced and/or metastatic pancreatic ductal adenocarcinoma by activating NF-κB-related signaling
por: Kuo, Sung-Hsin, et al.
Publicado: (2021)

SCF, Regulated by HIF-1α, Promotes Pancreatic Ductal Adenocarcinoma Cell Progression
por: Gao, Chuntao, et al.
Publicado: (2015)

TGIF1-Twist1 axis in pancreatic ductal adenocarcinoma
por: Razzaque, Mohammed S., et al.
Publicado: (2020)

SERP1 is a novel marker of poor prognosis in pancreatic ductal adenocarcinoma patients via anti-apoptosis and regulating SRPRB/NF-κB axis
por: Ma, Qiang, et al.
Publicado: (2017)

KPNB1-mediated nuclear import is required for motility and inflammatory transcription factor activity in cervical cancer cells
por: Stelma, Tamara, et al.
Publicado: (2017)

KPNB1 modulates the Machado–Joseph disease protein ataxin-3 through activation of the mitochondrial protease CLPP
por: Abeditashi, Mahkameh, et al.
Publicado: (2022)

Pancreatic and duodenal homeobox-1 in pancreatic ductal adenocarcinoma and diabetes mellitus
por: Tang, Zhen-Chu, et al.
Publicado: (2020)

Analysis of dynamic molecular networks for pancreatic ductal adenocarcinoma progression
por: Pan, Zongfu, et al.
Publicado: (2018)

Ion Channels Orchestrate Pancreatic Ductal Adenocarcinoma Progression and Therapy
por: Hofschröer, Verena, et al.
Publicado: (2021)

Role of the TRP Channels in Pancreatic Ductal Adenocarcinoma Development and Progression
por: Mesquita, Gonçalo, et al.
Publicado: (2021)

KRAS mutation: The booster of pancreatic ductal adenocarcinoma transformation and progression
por: Zhang, Zining, et al.
Publicado: (2023)

The Role of Exosomes in Pancreatic Ductal Adenocarcinoma Progression and Their Potential as Biomarkers
por: Hsu, Sheng-Kai, et al.
Publicado: (2023)

Mimics of pancreatic ductal adenocarcinoma
por: Al-Hawary, Mahmoud M., et al.
Publicado: (2013)

Pancreatic ductal adenocarcinoma staging
por: Al-Hawary, Mahmoud M., et al.
Publicado: (2013)

Syndecans and Pancreatic Ductal Adenocarcinoma
por: Betriu, Nausika, et al.
Publicado: (2021)

Models of pancreatic ductal adenocarcinoma
por: Dennaoui, Rayane, et al.
Publicado: (2021)

Impact of caveolin-1 expression on prognosis of pancreatic ductal adenocarcinoma
por: Suzuoki, M, et al.
Publicado: (2002)

Is Neoadjuvant Treatment Justified in Clinical T1 Pancreatic Ductal Adenocarcinoma?
por: Kim, Hyung Sun, et al.
Publicado: (2021)

Pancreatic Ductal Adenocarcinoma Associated with Autoimmune Pancreatitis
por: Pezzilli, Raffaele, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_4rvc8i88b0govsa5bsdq48be1l